Detecting cancer by liquid biopsy is attracting a lot of money and hype. Can it deliver on its promise to transform oncology? Sarah Webb reports.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors
BMC Cancer Open Access 05 February 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
01 December 2016
In the version of this article initially published, in Table 1, “Blood-based digital sequencing of gene panel of 70 single base mutations...” should have read, “Blood-based digital sequencing of single-base mutations in 70 genes...” The errors have been corrected in the HTML and PDF versions of the article.
References
Janku, F. et al. Oncotarget 5, 3607–3610 (2014).
Siravegna, G. et al. Nat. Med. 21, 795–801 (2015).
Tie, J. et al. Sci. Transl. Med. 8, 346ra92 (2016).
Garcia-Murillas, I. et al. Sci. Transl. Med. 7, 302ra133 (2015).
Schwaederle, M. et al. Oncotarget 7, 9707–9717 (2016).
Baselga, J. et al. San Antonio Breast Cancer Symposium. Abstract S6–01. Presented December 11, 2015.
Scher, C. et al. JAMA Oncol. doi:10.1001/jamaoncol.2016.1828 (2016).
Bettegowda, C. et al. Sci. Transl. Med. 6, 224ra24 (2014).
Sheridan, C. Nat. Biotechnol. 34, 359–360 (2016).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Webb, S. The cancer bloodhounds. Nat Biotechnol 34, 1090–1094 (2016). https://doi.org/10.1038/nbt.3717
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3717
This article is cited by
-
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors
BMC Cancer (2020)
-
Jury out on liquid biopsies for cancer
Nature Biotechnology (2018)
-
Erratum: The cancer bloodhounds
Nature Biotechnology (2017)
-
Grail to pour $1 billion into blood test to detect early cancer
Nature Biotechnology (2017)
-
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Nature Reviews Cancer (2017)